Tate & Lyle | TATE - Sales Revenues

Stock Price
357.40
Daily Change
4.60 1.30%
Monthly
-9.84%
Yearly
-33.57%
Q1 Forecast
348.20

Tate & Lyle reported GBP1.02B in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Agrana Beteiligungs EUR 802.4M 77.8M Sep/2025
Anglo-eastern Plants USD 230.47M 24.92M Jun/2025
Associated British Foods GBP 9.95B 441M Sep/2025
Austevoll Seafood NOK 9.41B 630M Dec/2025
Beiersdorf EUR 2.31B 40M Dec/2025
British American Tobacco GBP 13.5B 1.43B Dec/2025
Danone EUR 6.68B 200M Dec/2025
Diageo GBP 5.59B 3.76B Dec/2025
Givaudan CHF 1.87B 1.51B Jun/2024
Henkel EUR 10.09B 4.93B Dec/2025
Imperial Brands GBP 17.57B 8.91B Sep/2025
International Flavors Fragrances USD 2.59B 100M Dec/2025
Kerry EUR 3.88B 0 Dec/2024
L'Oréal EUR 21.58B 10.84B Dec/2025
Nestle CHF 44.23B 2.08B Jun/2025
Nomad Foods EUR 773M 21M Dec/2025
Ontex EUR 880.3M 882.4M Jun/2025
Pernod Ricard EUR 5.25B 2.87B Dec/2025
Premier Foods GBP 648M 385.6M Dec/2025
Primary Health Properties ZAR 89.7M 100K Jun/2025
Reckitt Benckiser GBP 7.26B 3.96B Dec/2025
Tate & Lyle GBP 1.02B 0 Dec/2025
Unilever EUR 12.59B 2.11B Dec/2025